Published 2021 Aug 23
Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
Long-term consumption of DDW can protect mice from cancer, and DDW has been shown to prolong survival of human cancer patients and to protect from relapse
Glutathione levels naturally decline with age, stress, and toxin exposure
A small, but influential, human study 30 found that L-Cysteine supplementation before drinking was associated with reduced nausea, headache, and anxiety the following day